RXMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RXMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:
1. GuruFocus internally developed valuations of the stock, such as GF valuation.Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.
Based on those aspects listed above, GuruFocus believes the risk assessment of Progressive Care is: No Data: Cannot be evaluated.
For the Pharmaceutical Retailers subindustry, Progressive Care's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Progressive Care's Risk Assessment distribution charts can be found below:
* The bar in red indicates where Progressive Care's Risk Assessment falls into.
Progressive Care (OTCPK:RXMD) Risk Assessment Explanation
Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:
(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.
Thank you for viewing the detailed overview of Progressive Care's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.
Charles M. Fernandez | director, 10 percent owner, officer: Chairman & CEO | C/O FAIRHOLME CAPITAL MANAGEMENT, L.L.C., 4400 BISCAYNE BOULEVARD, 9TH FLOOR, MIAMI FL 33137 |
Rodney Barreto | director, 10 percent owner | 460 MARQUESA DRIVE, CORAL GABLES FL 33156 |
Pamela M Roberts | officer: CHIEF OPERATING OFFICER | 1540 NW 203 ST, MIAMI FL 33169 |
Pedro Rodriguez | director | 258 NE 27TH STREET, MIAMI FL 33137 |
Birute Norkute | officer: Chief Operating Officer | 2311 NE 174TH ST, MIAMI FL 33160 |
Alan Jay Weisberg | officer: CHIEF FINANCIAL OFFICER | 2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431 |
Cecile Munnik | officer: CFO | 400 ANSIN BLVD SUITE A, HALLANDALE BEACH FL 33009 |
Joseph Ziegler | director | 1051 HILLSBORO MILE, PH2, HILLSBORO BEACH FL 33062 |
Jervis Hough | director | 6053 BARTAM COVE, DULUTH GA 30097 |
Shital P Parikh | director, officer: Chief Operating Officer | 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169 |
Vernon Watson | officer: Chief Executive Officer | 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169 |
Armen Karapetyan | 10 percent owner | 17395 NORTH BAY ROAD, SUITE 102, SUNNY ISLES BEACH FL 33160 |
Avraham A. Friedman | director, 10 percent owner, officer: Chief Executive Officer | C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162 |
Andy Subachan | director, 10 percent owner, officer: Chief Operating Officer | C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162 |
Buddy Young | director, 10 percent owner, officer: President, CEO, CFO, Chairman |
From GuruFocus
By GuruFocusNews GuruFocusNews • 07-02-2022
By PRNewswire • 11-20-2023
By Ds*** Ds*** • 08-31-2022
By GuruFocusNews GuruFocusNews • 06-12-2022
By PurpleRose PurpleRose • 08-05-2022
By PRNewswire • 11-27-2023
By GuruFocusNews GuruFocusNews • 05-27-2022
By PurpleRose PurpleRose • 08-12-2022
By sperokesalga sperokesalga • 05-11-2023
By Value_Insider Value_Insider • 11-15-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.